Malay Mail on MSN

Beyfortus (Nirsevimab) now available in Malaysia to help protect all infants against RSV disease

Sanofi and AstraZeneca’s Beyfortus (Nirsevimab) is now approved by the National Pharmaceutical Regulatory Agency (NPRA) and ...

FDA reviewing safety of RSV drugs for infants, no incidents reported

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

FDA Reviewing RSV Drugs for Infants, Though No Safety Issues Found

The U.S. Centers for Disease Control and Prevention (CDC) recommends Beyfortus or Enflonsia for babies younger than 8 months ...

FDA looks into reports of deaths after COVID vaccination

Federal officials say the U.S. Food and Drug Administration (FDA) is reviewing reports of possible deaths in adults and ...
Enquirer 360

FDA Reassesses Safety of Infant RSV Treatments

U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.